Published in J Neurosci on July 09, 2003
Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A (2006) 2.09
Sleep deprivation inhibits adult neurogenesis in the hippocampus by elevating glucocorticoids. Proc Natl Acad Sci U S A (2006) 1.46
Neuroplasticity in brain reward circuitry following a history of ethanol dependence. Eur J Neurosci (2008) 1.19
Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. Biol Psychiatry (2008) 1.14
Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity. Front Cell Neurosci (2014) 1.01
Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr Neuropharmacol (2011) 0.96
Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies. Neurobiol Learn Mem (2013) 0.96
Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan. Neuroscience (2012) 0.93
The mGluR2/3 agonist LY379268 induced anti-reinstatement effects in rats exhibiting addiction-like behavior. Neuropsychopharmacology (2013) 0.91
Lowering corticosterone levels reinstates hippocampal brain-derived neurotropic factor and Trkb expression without influencing deficits in hypothalamic brain-derived neurotropic factor expression in leptin receptor-deficient mice. Neuroendocrinology (2010) 0.90
Models and mechanisms for hippocampal dysfunction in obesity and diabetes. Neuroscience (2015) 0.89
Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. Eur J Pharmacol (2006) 0.86
Restraint stress alters nociceptin/orphanin FQ and CRF systems in the rat central amygdala: significance for anxiety-like behaviors. J Neurosci (2014) 0.85
Harmful algal bloom toxins alter c-Fos protein expression in the brain of killifish, Fundulus heteroclitus. Aquat Toxicol (2006) 0.84
Time-course of immediate early gene expression in hippocampal subregions of adrenalectomized rats after acute corticosterone challenge. Brain Res (2008) 0.82
Adolescent intermittent ethanol exposure enhances ethanol activation of the nucleus accumbens while blunting the prefrontal cortex responses in adult rat. Neuroscience (2015) 0.80
Protective effect of young green barley leaf (Hordeum vulgare L.) on restraint stress-induced decrease in hippocampal brain-derived neurotrophic factor in mice. Pharmacogn Mag (2015) 0.75
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature (1998) 6.27
Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol (1973) 3.54
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol (1970) 3.54
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol (1969) 2.61
Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol (1969) 2.26
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci (1997) 2.23
Cellular localization of monoamines in the area postrema of certain mammals. J Comp Neurol (1965) 2.13
Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmacol Toxicol (Copenh) (1966) 2.13
Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol (1967) 2.08
Localization of monoamines in the lower brain stem. Experientia (1964) 1.72
Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev (1987) 1.68
Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc Natl Acad Sci U S A (1986) 1.61
Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system. Proc Natl Acad Sci U S A (1986) 1.56
Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol Sci (1999) 1.54
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci U S A (2000) 1.53
Intercellular communication in the brain: wiring versus volume transmission. Neuroscience (1995) 1.50
Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand (1967) 1.49
Pharmacological studies on the hypotensive effects of clonidine. Eur J Pharmacol (1971) 1.49
High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J (1992) 1.48
Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res (1969) 1.47
Hypothermic effect of apomorphine in the mouse. J Pharm Pharmacol (1972) 1.43
Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression. J Neurosci (1993) 1.42
Power spectral analysis of EEG during sufentanil infusion in humans. Can J Anaesth (1991) 1.41
Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res (1993) 1.40
Adenosine-dopamine interactions in the brain. Neuroscience (1992) 1.39
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A (1991) 1.39
Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia. Science (1974) 1.38
Effect of apomorphine on the GABA turnover in the DA cell group rich area of the mesencephalon. Evidence for the involvement of an inhibitory gabergic feedback control of the ascending DA neurons. Neurosci Lett (1975) 1.38
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A (2000) 1.38
Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol Rev (1966) 1.37
Prognosis for patients treated conservatively for spontaneous intracerebral hematomas. Stroke (1985) 1.34
Adrenergic and cholinergic nerve terminals in skeletal muscle vessels. Acta Physiol Scand (1970) 1.34
The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology (1971) 1.33
Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res (1997) 1.33
Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci (1970) 1.33
Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology (1985) 1.32
ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors. Eur J Pharmacol (1972) 1.31
Histochemical amd biochemical effects of diethyldithiocarbamate on tissue catecholamines. J Pharm Pharmacol (1966) 1.29
On the projections from the locus coeruleus noradrealine neurons: the cerebellar innervation. Brain Res (1971) 1.29
Evidence for a new type of dopamine receptor stimulating agent. J Pharm Pharmacol (1971) 1.27
Characterization and tissue localization of catecholamine synthesizing enzymes. Pharmacol Rev (1972) 1.27
Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons. Neuroendocrinology (1972) 1.27
Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur J Pharmacol (1975) 1.27
Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res (1972) 1.26
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon. Life Sci (1965) 1.23
The effect of some psychoactive drugs on central monoamine neurons. Eur J Pharmacol (1967) 1.23
The effect of immobilization stress on the activity of central monoamine neurons. Life Sci (1968) 1.22
Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study. Exp Brain Res (1979) 1.22
The effect of imipramine on central 5-hydroxytryptamine neurons. J Pharm Pharmacol (1968) 1.21
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. Neuropsychopharmacology (2000) 1.20
The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J Neural Transm (Vienna) (2009) 1.20
Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation. Med Biol (1974) 1.20
The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J Neurosci (1993) 1.18
A possible role played by central monoamine neurones in thermo-regulation. Acta Physiol Scand (1968) 1.17
The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology (1999) 1.17
Partial advance information and response preparation: inferences from the lateralized readiness potential. J Exp Psychol Gen (1996) 1.15
Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Br J Pharmacol (1968) 1.15
Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal processes. J Comp Neurol (1985) 1.14
Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors. J Pharm Pharmacol (1972) 1.13
The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci Lett (1998) 1.12
Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms. J Neural Transm (Vienna) (2006) 1.11
The emergence of the volume transmission concept. Brain Res Brain Res Rev (1998) 1.11
Mapping and computer assisted morphometry and microdensitometry of glucocorticoid receptor immunoreactive neurons and glial cells in the rat central nervous system. Neuroscience (1994) 1.11
Effect of prostaglandin E 2 on central and peripheral catecholamine neurons. Eur J Pharmacol (1973) 1.09
Further mapping of central 5-hydroxytryptamine neurons: studies with the neurotoxic dihydroxytryptamines. Adv Biochem Psychopharmacol (1974) 1.09
ERP correlates of error processing in spatial S-R compatibility tasks. Clin Neurophysiol (1999) 1.09
Evidence for adrenaline neurons in the rat brain. Acta Physiol Scand (1973) 1.08
A cluster of differentially expressed signal transduction genes identified by microarray analysis in a rat genetic model of alcoholism. Pharmacogenomics J (2004) 1.08
Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res (1996) 1.08
Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. Biochem Pharmacol (1999) 1.07
Neuropeptide Y in vitro selectivity increases the number of alpha 2-adrenergic binding sites in membranes of the medulla oblongata of the rat. Acta Physiol Scand (1983) 1.07
Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia. Neuroreport (1997) 1.06
Histochemical studies on the distribution of catecholamines and 5-hydroxytryptamine after intraventricular injections. Histochemie (1968) 1.06
Localization of glucocorticoid receptor mRNA in the male rat brain by in situ hybridization. Proc Natl Acad Sci U S A (1988) 1.06
DL-5-hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition. J Pharm Pharmacol (1971) 1.06
Functional regeneration of 5-hydroxytryptamine nerve terminals in the rat spinal cord following 5, 6-dihydroxytryptamine induced degeneration. Brain Res (1974) 1.06
Production of discrete changes in dopamine and noradrenaline levels and turnover in various parts of the rat brain following exposure to xylene, ortho-, meta-, and para-xylene, and ethylbenzene. Toxicol Appl Pharmacol (1981) 1.05
Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin-1, -2 and -5 expression by protein kinase C. Neuroreport (2000) 1.05
Adenosine A2A agonists: a potential new type of atypical antipsychotic. Neuropsychopharmacology (1997) 1.04
Prominent expression of acidic fibroblast growth factor in motor and sensory neurons. Neuron (1991) 1.04
Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats. Eur J Pharmacol (1978) 1.04
Histochemical studies on the effect of (positive)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine. Eur J Pharmacol (1968) 1.04
Changes in dialysate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions? J Neurochem (2003) 1.04
The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol (1996) 1.04
Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus. Neuroendocrinology (1992) 1.03
Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain. I. Tyrosine hydroxylase in the mes- and diencephalon. Med Biol (1976) 1.03
Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol Psychiatry (1997) 1.02
Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci Lett (2002) 1.02
Volume transmission and wiring transmission from cellular to molecular networks: history and perspectives. Acta Physiol (Oxf) (2006) 1.02
The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Neuropsychopharmacology (2001) 1.02
Corticosterone actions on the hippocampal brain-derived neurotrophic factor expression are mediated by exon IV promoter. J Neuroendocrinol (2006) 1.02